Pharmacokinetics of betaxolol in middle aged patients
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 31 (2) , 231-233
- https://doi.org/10.1007/bf00606665
Abstract
The pharmacokinetics of betaxolol was studied in 8 middle-aged (40–60 years) subjects after oral (20 mg) and intravenous (10 mg) administration. The principal parameters were almost identical to those observed in young healthy volunteers. The recommended therapeutic regimen, a single daily dose of 20 mg, appears well suited for middle aged, hypertensive patients.Keywords
This publication has 8 references indexed in Scilit:
- Betaxolol kinetics in hypertensive children with normal and abnormal renal functionClinical Pharmacology & Therapeutics, 1984
- PHARM—An interactive graphic program for individual and population pharmacokinetic parameter estimationComputers in Biology and Medicine, 1984
- Improved determination of betaxolol in biological samples by capillary column gas chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta‐adrenoceptor antagonist after oral and intravenous administration.British Journal of Clinical Pharmacology, 1980
- Beta‐adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.British Journal of Clinical Pharmacology, 1980
- Cardiovascular effects of single oral doses of the new beta- adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.Published by Wiley ,1980
- Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.1980